136 related articles for article (PubMed ID: 26153577)
61. Severe non-rheumatic streptococcal myocarditis requiring extracorporeal membrane oxygenation support.
Fox-Lewis A; Merz TM; Hennessy I
Lancet Infect Dis; 2020 Dec; 20(12):1481. PubMed ID: 33248041
[No Abstract] [Full Text] [Related]
62. Invasive group A streptococcal disease.
Stevens DL
Infect Agents Dis; 1996 Jun; 5(3):157-66. PubMed ID: 8805078
[TBL] [Abstract][Full Text] [Related]
63. Clindamycin in persisting streptococcal pharyngotonsillitis after penicillin treatment.
Orrling A; Stjernquist-Desatnik A; Schalén C; Kamme C
Scand J Infect Dis; 1994; 26(5):535-41. PubMed ID: 7855551
[TBL] [Abstract][Full Text] [Related]
64. Prenatal culture-based screening of Streptococcus agalactiae colonisation: resistance against erythromycin and clindamycin.
Lavergne V; Laverdière M; Duchesne A; Béliveau C; Delorme J; Di Zazzo A; Labbé AC
Eur J Clin Microbiol Infect Dis; 2006 Aug; 25(8):532-4. PubMed ID: 16874484
[No Abstract] [Full Text] [Related]
65. [Clustered cases of intrafamily invasive Streptococcus pyogenes infection (or group A streptococcus)].
Caillet-Gossot S; Rousset-Rouviere C; Arlaud K; Dubus JC; Bosdure E
Arch Pediatr; 2011 Dec; 18(12):1305-9. PubMed ID: 22056211
[TBL] [Abstract][Full Text] [Related]
66. [Clinical characteristics and antimicrobial resistance of invasive group A β-hemolytic streptococcus infection in children].
Fan J; Dong L; Chen Z; Bei D
Zhonghua Er Ke Za Zhi; 2014 Jan; 52(1):46-50. PubMed ID: 24680408
[TBL] [Abstract][Full Text] [Related]
67. Antimicrobial Susceptibility of Invasive Streptococcus pyogenes Isolates in Germany during 2003-2013.
Imöhl M; van der Linden M
PLoS One; 2015; 10(9):e0137313. PubMed ID: 26340445
[TBL] [Abstract][Full Text] [Related]
68. Clinical and epidemiologic features of invasive group A streptococcal infections in children.
Mulla ZD
Pediatr Int; 2007 Jun; 49(3):355-8. PubMed ID: 17532835
[TBL] [Abstract][Full Text] [Related]
69. Toxic shock syndrome due to group A streptococcal pharyngitis and bacteremia in an adult.
Vucicevic Z; Bencic IJ; Kruslin B; Degoricija V
J Microbiol Immunol Infect; 2008 Aug; 41(4):351-4. PubMed ID: 18787744
[TBL] [Abstract][Full Text] [Related]
70. Severe cellulitis caused by group A streptococcus: Rx reading the Journal.
Fried M; Rudensky B; Golan J; Sternberg N; Isaacsohn M; Ben Hur N
J Infect Dis; 1990 Jan; 161(1):155. PubMed ID: 2404075
[No Abstract] [Full Text] [Related]
71. An unusual presentation of peritonsillar abscess.
Carstairs KL; McCaslin I
Pediatr Emerg Care; 2004 Oct; 20(10):680-2. PubMed ID: 15454744
[No Abstract] [Full Text] [Related]
72. [Bacteriological study on clindamycin-2-palmitate (author's transl)].
Ono H; Otsuki M; Nakazawa S
Jpn J Antibiot; 1973 Aug; 26(4):321-4. PubMed ID: 4582578
[No Abstract] [Full Text] [Related]
73. Severe group A streptococcal toxic shock syndrome presenting as primary peritonitis: a case report and brief review of the literature.
Tilanus AM; de Geus HR; Rijnders BJ; Dwarkasing RS; van der Hoven B; Bakker J
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e208-12. PubMed ID: 19914115
[TBL] [Abstract][Full Text] [Related]
74. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
[TBL] [Abstract][Full Text] [Related]
75. Clindamycin phosphate in severe infections mainly caused by Bacteroides fragilis: clinical and microbiological evaluation.
Schoutens E; Van Beers D; Yourassowsky E
Infection; 1974; 2(2):59-63. PubMed ID: 4367028
[No Abstract] [Full Text] [Related]
76. A 7-year-old boy with acute onset of breathing difficulty.
Salas AA
Pediatr Emerg Care; 2010 Feb; 26(2):149-51. PubMed ID: 20145509
[TBL] [Abstract][Full Text] [Related]
77. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
[TBL] [Abstract][Full Text] [Related]
78. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
Rodríguez-Zurita ME; Solís del Baño S; Robres Guillén P; González Praetorius A; Gimeno Fernández C; Pérez Pomata MT; Bisquert Santiago J
Rev Esp Quimioter; 2003 Mar; 16(1):61-4. PubMed ID: 12750759
[TBL] [Abstract][Full Text] [Related]
79. Serotyping and susceptibility to macrolides and other antimicrobial drugs of Streptococcus pyogenes isolated from patients with invasive diseases in southern Israel.
Weiss I; Gorodnitzky Z; Korenman Z; Yagupsky P
Eur J Clin Microbiol Infect Dis; 1997 Jan; 16(1):20-3. PubMed ID: 9063669
[TBL] [Abstract][Full Text] [Related]
80. Current issues in managing group A streptococcal infections.
Carapetis JR
Adv Exp Med Biol; 2004; 549():185-90. PubMed ID: 15250532
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
